Enhancing Biopharma’s Path-to-Market: Optimising Clinical Success and Commercial Outcomes Webinar | July 2024
Watch on demand Exploristics recent webinar Enhancing Biopharma’s Path-to-Market: Optimising Clinical Success and Commercial Outcomes, co-hosted by industry experts Jacqueline Barendregt from IDEA Pharma and Aiden Flynn from Exploristics.
In this comprehensive session, we explore the concept of design-thinking path-to-market strategies, which are increasingly being recognised as pivotal in the biopharma sector. By integrating these strategies with cutting-edge analytics and simulation methods, biopharma companies can gain invaluable insights that enhance strategic decision-making processes.
Jacqueline Barendregt, a renowned expert from IDEA Pharma, has been instrumental in guiding numerous biopharma companies through complex market challenges.
Aiden Flynn, the CEO of Exploristics, shares his unique perspective on how advanced analytics can be harnessed to drive clinical success. Aiden presents recent case studies, including Alzheimer’s clinical trial that showcases how Exploristics’ solutions have been pivotal in achieving clinical milestones.
Attendees will a receive a demonstration of KerusCloud, Exploristics’ state-of-the-art platform designed to enhance clinical trial design through simulation. KerusCloud leverages advanced simulation techniques to provide researchers with a robust tool for optimising trial outcomes and reducing study time. This demonstration will highlight how KerusCloud can be utilised to streamline the trial process, reduce costs, and improve the likelihood of success.
Aiden and Jacqueline also share their experiences and insights on the strategies that drive success in the highly competitive biopharma landscape. This discussion provides attendees with a broad perspective on the various approaches that can be adopted to navigate the complexities of bringing new therapies to market.
This webinar is a must-attend for biopharma leaders and professionals across various disciplines, including research and development, clinical development, regulatory affairs, new product planning, and commercial. Whether your organisation is directly involved in the clinical trial process or plays vital a role in the broader market strategy.
This holistic approach ensures that your organisation can effectively bring innovative therapies to market, ultimately improving patient outcomes and driving business growth.
To register for the webinar, please fill in the registration form below.